Lumos Diagnostics Holdings Ltd News - LDX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Lumos Diagnostics Appoints Doug Ward as CEO

SARASOTA, Fla., June 21, 2022 (GLOBE NEWSWIRE) -- Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies...

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced...

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Journal of Health Economics and Outcomes Research Publishes Cost Impact of the Novel, Rapid Point-of-Care...

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced...

Lumos Diagnostics FY21 Full Year Results

HIGHLIGHTS Annual revenues of A$25.0 million, up 198% from FY20 Commercial Services business unit delivered...

Lumos Diagnostics Raises $63M AUD in ASX IPO

Global, innovative rapid point-of-care diagnostic company plans expansion and commercialization of suite of...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lumos Diagnostics Holdings Ltd (LDX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LDX News

Lumos Diagnostics Appoints Doug Ward as CEO

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

Lumos Diagnostics FY21 Full Year Results

Lumos Diagnostics Raises $63M AUD in ASX IPO

LDX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Lumos Diagnostics Holdings Ltd (LDX) News

Lumos Diagnostics Holdings Ltd (LDX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

LDX News

Lumos Diagnostics Appoints Doug Ward as CEO

Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada

Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually

Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser

Lumos Diagnostics FY21 Full Year Results

Lumos Diagnostics Raises $63M AUD in ASX IPO

LDX Discussion

Your Recent History